Researchers make the argument for increasing vitamin D supplementation in low- and middle-income countries, where vaccines and other methods of COVID prevention may be less available. Maintaining adequate vitamin D levels could play a critical role in protecting against serious illness or death from COVID-19, according to new Israeli research. The study, published last week […] Continue reading ->
Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading ->
An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading ->
Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading ->
Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading ->
Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading ->
In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading ->
A fourth COVID-19 booster mRNA vaccine has proven ineffective against Omicron infection, according to preliminary research from Israel released on Monday. “Despite a significant increase in antibodies after the fourth vaccine, this protection is only partially effective against the Omicron strain, which is relatively resistant to the vaccine,” lead researcher Prof Gili Regev-Yochay, told a […] Continue reading ->
Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading ->
Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading ->